Income Statement Apex Science & Engineering Corp.
Stocks
3052
TW0003052007
Real Estate Development & Operations
|
End-of-day quote
Taiwan S.E.
06/10/2026
|
5-day change | 1st Jan Change | ||
| 10.45 TWD | 0.00% |
|
+0.48% | -13.28% |
| 09-16 | Apex Science & Engineering OKs NT$3.87 Billion Urban Renewal Plan | MT |
| 08-12 | Apex Science & Engineering Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Fiscal Period: December | 2016 (TWD) | 2017 (TWD) | 2018 (TWD) | 2019 (TWD) | 2020 (TWD) | 2021 (TWD) | 2022 (TWD) | 2023 (TWD) | 2024 (TWD) | 2025 (TWD) |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3.61B | 2.95B | 3.48B | 2.66B | 3.42B | |||||
Total Revenues | 3.61B | 2.95B | 3.48B | 2.66B | 3.42B | |||||
Cost of Goods Sold, Total | 3.41B | 2.58B | 3.1B | 2.3B | 2.99B | |||||
Gross Profit | 205M | 367M | 388M | 361M | 430M | |||||
Selling General & Admin Expenses, Total | 135M | 156M | 164M | 168M | 165M | |||||
Provision for Bad Debts | 97K | 1.69M | - | - | 771K | |||||
R&D Expenses | 1.83M | 2.75M | 2.03M | 2.3M | 1.8M | |||||
Other Operating Expenses, Total | 137M | 160M | 166M | 170M | 167M | |||||
Operating Income | 67.96M | 207M | 222M | 191M | 263M | |||||
Interest Expense, Total | -21.66M | -16.14M | -22.47M | -32.96M | -32.1M | |||||
Interest And Investment Income | 61.33M | 33.38M | 41.73M | 62.85M | 37.03M | |||||
Net Interest Expenses | 39.67M | 17.24M | 19.26M | 29.89M | 4.93M | |||||
Income (Loss) On Equity Invest. | 30.88M | 31.34M | 25.41M | 7.75M | - | |||||
Currency Exchange Gains (Loss) | -527K | 11.45M | -577K | 7.49M | -1.34M | |||||
Other Non Operating Income (Expenses) | 1.34M | 8.27M | 7.46M | 3.29M | 12.45M | |||||
EBT, Excl. Unusual Items | 139M | 275M | 273M | 239M | 279M | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | -13.23M | - | |||||
Gain (Loss) On Sale Of Assets | -173K | 205K | 8K | 28M | - | |||||
Asset Writedown | - | - | - | - | - | |||||
Other Unusual Items | - | - | 5K | - | - | |||||
EBT, Incl. Unusual Items | 139M | 276M | 273M | 254M | 279M | |||||
Income Tax Expense | 33.14M | 67.11M | 66.07M | 50.86M | 52.86M | |||||
Earnings From Continuing Operations | 106M | 208M | 207M | 203M | 226M | |||||
Net Income to Company | 106M | 208M | 207M | 203M | 226M | |||||
Minority Interest | -3.27M | -1.48M | -2.38M | -3.22M | -1.76M | |||||
Net Income - (IS) | 103M | 207M | 205M | 200M | 224M | |||||
Net Income to Common Incl Extra Items | 103M | 207M | 205M | 200M | 224M | |||||
Net Income to Common Excl. Extra Items | 103M | 207M | 205M | 200M | 224M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.5 | 1.01 | 1.02 | 0.98 | 1.1 | |||||
Basic EPS - Continuing Operations | 0.5 | 1.01 | 1.02 | 0.98 | 1.1 | |||||
Basic Weighted Average Shares Outstanding | 206M | 205M | 201M | 204M | 204M | |||||
Net EPS - Diluted | 0.49 | 1 | 1.01 | 0.97 | 1.09 | |||||
Diluted EPS - Continuing Operations | 0.49 | 1 | 1.01 | 0.97 | 1.09 | |||||
Diluted Weighted Average Shares Outstanding | 208M | 208M | 204M | 206M | 206M | |||||
Normalized Basic EPS | 0.41 | 0.83 | 0.84 | 0.72 | 0.85 | |||||
Normalized Diluted EPS | 0.4 | 0.82 | 0.83 | 0.71 | 0.84 | |||||
Dividend Per Share | 0.24 | 0.38 | 0.39 | 0.5 | 0.6 | |||||
Payout Ratio | 156.3 | 24.25 | 38.82 | 40.6 | 46.03 | |||||
Supplemental Items | ||||||||||
EBITDA | 73.01M | 212M | 227M | 197M | 270M | |||||
EBITA | 69.35M | 209M | 223M | 193M | 266M | |||||
EBIT | 67.96M | 207M | 222M | 191M | 263M | |||||
Effective Tax Rate - (Ratio) | 23.82 | 24.36 | 24.18 | 20.04 | 18.96 | |||||
Total Current Taxes | 10.98M | 8.03M | 23.07M | 72.5M | 49.22M | |||||
Total Deferred Taxes | 22.16M | 59.08M | 43.01M | -21.64M | 3.65M | |||||
Normalized Net Income | 83.81M | 171M | 168M | 146M | 172M | |||||
Interest Capitalized | 46.62M | 60.97M | 78.01M | 68.26M | 41.87M | |||||
Interest on Long-Term Debt | 6.46M | 3.39M | 3.4M | 3.4M | 3.4M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 36.98M | 37.79M | 40.57M | 37.49M | 34.57M | |||||
General and Administrative Expenses | 98.04M | 118M | 124M | 131M | 130M | |||||
Research And Development Expense From Footnotes | 1.83M | 2.75M | 2.03M | 2.3M | 1.8M |
Select your edition
All financial news and data tailored to specific country editions
















